Chemical synthesis of potential inhibitors. Reagents and solvents were from Aldrich, Alfa Aesar or Acros. Reactions were monitored by TLC, which was performed on precoated aluminum-backed plates (Merck, silica 60 F254). Melting points were determined using a Leica Galen III hot-stage melting point apparatus and microscope. Infrared spectra were recorded from Nujol mulls between sodium chloride discs, on a Bruker Tensor 27 FT-IR spectrometer. NMR spectra were acquired using a Bruker DPX500 NMR spectrometer. Chemical shifts (δ) are given in ppm, and the multiplicities are given as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), broad (br). Coupling constants
J are given in Hz (± 0.5 Hz). High resolution mass spectra (HRMS) were recorded using a Bruker MicroTOF spectrometer. The purity of all compounds synthesized were ≥95% as determined by analytical reverse-phase HPLC (Ultimate 3000). Daminozide (Alar
™) and compound
28 are commercially available. The synthesis and characterisation of compounds
2225 ,
2526 (link),
2727 ,
3628 ,
3729 and
3826 (link) has been reported. The synthesis of compounds
31-35,
39-41 and
13C NMR spectra for
22,
23,
24,
26,
31-35 are given in the
Supporting Information.
4-(2,2,2-Trimethylhydrazinyl)-4-oxobutanoate
22. The synthesis of compound
22 was as reported
25 , thus reaction of daminozide (500mg, 3.1 mmol) with methyl iodide (700mg, 0.31 mL, 5.0 mmol) gave 22 as a white solid (75% yield), mp: 137-138 °C (lit.1 137-138.5 °C);
1H NMR (500 MHz, MeOD): δ 2.40 (t,
J = 6.5 Hz, 2H), 2.51 (t,
J = 6.5 Hz, 2H), 3.56 (s, 9H);
13C NMR (125 MHz, MeOD): δ 28.5, 29.1, 56.1, 170.4, 173.4; IR (neat)
υ/cm
−1: 3405, 3312, 1729, 1693; HRMS (m/z): [M]+ calcd. for C
7H
15N
2O
3, 175.1077; found, 175.1081.
General procedure for the coupling of hydrazine to succinic anhydride. To a stirred solution of the appropriate hydrazine (1 equiv.) in acetonitrile (5 mL) was added dropwise a solution of succinic anhydride (200 mg, 2.0 mmol, 1 equiv.) in acetonitrile (5 mL). The mixture was stirred at room temperature for 24 h, after which the solvent was evaporated
in vacuo and the resulting crude purified using semipreparative reverse-phase HPLC, performed on a phenomenex C18 column (150 mm × 4.6 mm). Separation was achieved using a linear gradient of solvent A (water + 0.1% CF
3CO
2H) and solvent B (acetonitrile + 0.1% CF
3CO
2H), eluting at a flow rate of 1 mL/min and monitoring at 220 nm: 0% B to 40% B over 30 min.
4-(2-Methylhydrazinyl)-4-oxobutanoic acid
23. Compound 23 is a colourless oil (63% yield),
1H NMR (500 MHz, DMSO-d6): δ 2.35 (t,
J = 7.0 Hz, 2H), 2.68 (t,
J = 7.0 Hz, 2H), 2.98 (s, 3H), 4.76 (s, 1H), 7.74 (s, 1H);
13C NMR (125 MHz, DMSO-d6): δ 28.3, 29.1, 170.1, 173.6; IR (neat)
υ/cm
−1: 33 3219, 3057, 1708, 1632; HRMS (m/z): [M+Na]+ calcd. for C
5H
10N
2NaO
3, 169.0584; found, 169.0577.
4-Hydrazinyl-4-oxobutanoic acid
24. Compound 24 is a colourless oil (87% yield),
1H NMR (500 MHz, DMSO-d6): δ 2.34 (t,
J = 7.0 Hz, 2H), 2.60 (t,
J = 7.0 Hz, 2H), 5.86 (s, 1H), 8.99 (s, 1H);
13C NMR (125 MHz, DMSO-d6): δ 28.2, 29.1, 170.8, 173.9; IR (neat)
υ/cm
−1: 3303, 3290, 3199, 1712, 1624; HRMS (m/z): [M-H]- calcd. for C
4H
7N
2O
3, 131.0462; found, 131.0468.
4-Oxo-4-(1,2,2-trimethylhydrazinyl)butanoic acid
26. Compound 26 is a white solid (56% yield), mp: 97-98 °C,
1H NMR (500 MHz, DMSO-d6): δ 2.37 (t,
J = 7.0 Hz, 2H), 2.66 (t,
J = 7.0 Hz, 2H), 2.74 (s, 3H), 11.98 (s, 1H);
13C NMR (125 MHz, DMSO-d6): δ 28.2, 29.8, 43.4, 48.7, 173.5, 175.0; IR (neat)
υ/cm
−1: 2958, 1723, 1615; HRMS (m/z): [M+Na]+ calcd. for C
7H
14N
2NaO
3, 197.0897; found, 197.0895.
4-((Dimethylamino)oxy)-4-oxobutanoic acid
29.
N,
N-Dimethylhydroxylamine (39 mg, 0.63 mmol, 1.1 equiv. ) was added to a solution of 4-(tert-butoxy)-4-oxobutanoic acid (100 mg, 0.57 mmol, 1 equiv.), hydroxybenzotriazole (100 mg, 0.74 mmol, 1.3 equiv.), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide ( 140 mg, 0.74 mmol, 1.3 equiv.) and diisopropylethylamine ( 0.2 mL, 1.14 mmol, 2.0 equiv.) in CH
2Cl
2 (10 mL). The reaction was stirred at room temperature overnight, washed with water, HCl 1N, brine, dried on MgSO
4. The organic phase was evaporated
in vacuo and purified by chromatography (MeOH/CH
2Cl
2 0.5/9.5) to obtain 110 mg of tert-butyl 4((dimethylamino)oxy)-4-oxobutanoate (90% yield). CF
3CO
2H (0.04 ml, 0.37 mmol, 4 equiv.) was added to a solution of tert-butyl 4((dimethylamino)oxy)-4-oxobutanoate (20 mg, 0.09 mmol, 1 equiv.) in CH
2Cl
2 (1.5 ml). The reaction was stirred at room temperature for 4h and evaporated
in vacuo to give 14 mg of 29 (yield 95%).
1H NMR (500 MHz, CD
3OD) δ 2.59 (s, 6H), 2.57 (s, 4H);
13C NMR (500 MHz, CD
3OD) δ 176.2, 172.0, 48.5, 29.9; IR (neat) 3341, 2485,1717, 1120, 1026, 975 cm
−1; HRMS (m/z):[M+]calcd. for C
6H
11NO
4 161.0688; found 161.0923.
N‘1,
N‘1,
N‘4,
N‘4-Tetramethylsuccinohydrazide
30. A solution of succinic acid (100 mg, 0.85 mmol, 1 equiv.), hydroxybenzotriazole (350 mg, 2.11 mmol, 2.3 equiv.), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (421 mg, 2.11 mmol, 2.3 equiv.), diisopropylethylamine (0.6 mL, 3.4 mmol, 4 equiv.) and 1,1-dimethylhydrazine (0.16 mL, 2.04 mmol, 2.2 equiv.) in CH
2Cl
2 (20 mL) was stirred at room temperature overnight. CH
2Cl
2 (10 mL) was added and the reaction mixture was washed with water, a saturated solution of NaHCO
3, brine and dried on MgSO
4. The organic phase was evaporated in vacuo and purified by chromatography (MeOH/ CH
2Cl
2 1/9) to give 77 mg of 30 (45% yield).
1H NMR (500 MHz, CD
3OD) δ 2.87 (s, 6H), 2.65 (s, 2H);
13C NMR (500 MHz, CD
3OD) δ 178.2, 43.8, 27.6; IR (neat) 3356, 2485, 2071, 1695, 1120, 1027, 974 cm
−1; HRMS (m/z):[(M-2CH3)
−]calcd. for C
6H
14N
4O
2, 174.1117; found, 174.1022.
Rose N.R., Woon E.C., Tumber A., Walport L.J., Chowdhury R., Li X.S., King O.N., Lejeune C., Ng S.S., Krojer T., Chan M.C., Rydzik A.M., Hopkinson R.J., Che K.H., Daniel M., Strain-Damerell C., Gileadi C., Kochan G., Leung I.K., Dunford J., Yeoh K.K., Ratcliffe P.J., Burgess-Brown N., von Delft F., Muller S., Marsden B., Brennan P.E., McDonough M.A., Oppermann U., Klose R.J., Schofield C.J, & Kawamura A. (2012). The Plant Growth Regulator Daminozide is a Selective Inhibitor of the Human KDM2/7 Histone Demethylases. Journal of medicinal chemistry, 55(14), 6639-6643.